Hartleys gives a buy with a target price of 17c per share so why srr is still at more than 50% discount?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025